Broadly neutralizing human antibodies against Omicron subvariants of SARS-CoV-2

Broadly neutralizing human antibodies against Omicron subvariants of SARS-CoV-2

Abstract Background The COVID-19 pandemic continues to pose a significant worldwide threat to human health, as emerging SARS-CoV-2 Omicron variants exhibit resistance to therapeutic antibodies and the ability to evade vaccination-induced antibodies. Here, we aimed to identify human antibodies (hAbs)...

Full description

Bibliographic Details
Main Authors: Hsiao-Ling Chiang, Kang-Hao Liang, Ruei-Min Lu, Ting-Wen Kuo, Yi‑Ling Lin, Han-Chung Wu
Format: Article
Language:English
Published: BMC 2023-07-01
Series:Journal of Biomedical Science
Subjects:
Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2)
Omicron
XBB.1.5
BQ.1.1
Single B cell cloning
Neutralizing human antibody
Online Access:https://doi.org/10.1186/s12929-023-00955-x

Similar Items

Similar Items